Posts

Showing posts with the label sars prevention

Taiwan able to face COVID-19 with experience from SARS - Anadolu Agency

Taiwan able to face COVID-19 with experience from SARS    Anadolu Agency

Moderna hits COVID-19 case goal for vaccine candidate, results imminent - Boston Herald

Moderna hits COVID-19 case goal for vaccine candidate, results imminent    Boston Herald

US hits record for COVID-19 hospital cases - CIDRAP

US hits record for COVID-19 hospital cases    CIDRAP

Guest Opinion: Prioritize prevention; flu vaccines work - Idaho County Free Press

Guest Opinion: Prioritize prevention; flu vaccines work    Idaho County Free Press

Coronavirus kills 15,000 U.S. mink, as Denmark prepares for nationwide cull - Reuters

Coronavirus kills 15,000 U.S. mink, as Denmark prepares for nationwide cull    Reuters

The WHO is hunting for the coronavirus’s origins. Here are the new details. - National Geographic

The WHO is hunting for the coronavirus’s origins. Here are the new details.    National Geographic

Hydroxychloroquine in the prevention of COVID-19 mortality - The Lancet

Hydroxychloroquine in the prevention of COVID-19 mortality    The Lancet

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination - The Lancet

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination    The Lancet

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro - News-Medical.Net

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro    News-Medical.Net

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection - pnas.org

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection    pnas.org

Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces - News-Medical.Net

Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces    News-Medical.Net

Tru-D SmartUVC proven to inactivate SARS-CoV-2 - PRNewswire

Tru-D SmartUVC proven to inactivate SARS-CoV-2    PRNewswire

T-Cell Responses to SARS-CoV-2 Still Present Six Months After Initial Infection - Technology Networks

T-Cell Responses to SARS-CoV-2 Still Present Six Months After Initial Infection    Technology Networks

SARS-CoV-2 Infection Revealed in “Mini-Lungs” Shows How COVID-19 Damages the Lungs - SciTechDaily

SARS-CoV-2 Infection Revealed in “Mini-Lungs” Shows How COVID-19 Damages the Lungs    SciTechDaily

Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces - News-Medical.Net

Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces    News-Medical.Net

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study - The Lancet

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study    The Lancet

Researchers seeking volunteers for COVID-19 vaccine study - Newswise

Researchers seeking volunteers for COVID-19 vaccine study    Newswise

HiFiBiO advances trial of SARS-CoV-2 neutralizing antibodies - The Science Board

HiFiBiO advances trial of SARS-CoV-2 neutralizing antibodies    The Science Board

Fact check: This CDC document does not say that that SARS-CoV-2 doesn’t exist - Reuters

Fact check: This CDC document does not say that that SARS-CoV-2 doesn’t exist    Reuters

Face Shields Staved Off COVID-19, HAIs at Texas Hospital - MedPage Today

Face Shields Staved Off COVID-19, HAIs at Texas Hospital    MedPage Today